Search | Page 19 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. AML Therapy With Irradiated Allogeneic Cells

    ... myeloid leukemia (AML) from coming back after standard chemotherapy induces a complete remission. Blood cells obtained from a ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  2. MDS Progression to AML: What Patients Need to Know

    ... myeloid leukemia (AML), which does not respond well to chemotherapy . AML is a bone marrow malignancy where the marrow is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  3. What is Secondary MDS? Everything You Need to Know

    ... who have been previously treated for cancer with chemotherapy or radiation therapy. In this webinar, Dr. Walker ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  4. What is Secondary MDS? Everything You Need to Know

    ... who have been previously treated for cancer with chemotherapy or radiation therapy. During this recorded program on May ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  5. MDS Progression to AML: What Patients Need to Know

    ... myeloid leukemia (AML), which does not respond well to chemotherapy . AML is a bone marrow malignancy where the marrow is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  6. Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

    ... therapies At least 3 weeks beyond the last chemotherapy , targeted anticancer agent, major surgery or experimental ...

    Clinical Trial last updated 06/06/2016 - 10:47am.

  7. Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma

    ... is effective as a single agent and in combination with chemotherapy for indolent Non-Hodgkin's Lymphoma. The purpose of this ...

    Clinical Trial last updated 06/06/2016 - 10:17am.

  8. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... also approved by the FDA. Melphalan is an FDA-approved chemotherapy for multiple myeloma and is used as a high-dose conditioning ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  9. Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia or Acute Leukemia in Remission

    ... and symptoms of myelodysplasia or acute leukemia. Giving chemotherapy , such as clofarabine and melphalan, before a donor stem cell ...

    Clinical Trial last updated 05/03/2016 - 11:55am.

  10. Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia (VITAL)

    ... with untreated acute myeloid leukemia. Drugs used in chemotherapy , such as vosaroxin and cytarabine, work in different ways to ...

    Clinical Trial last updated 05/03/2016 - 11:51am.